Omara Khan
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Renal cell carcinoma treatment 3
- Co-authors
- Robert John Motzer (1 shared paper)Daniil Stroyakovskiy (1 shared paper)Frede N. Donskov (1 shared paper)Sarita Dubey (1 shared paper)B. Yа. Alekseev (1 shared paper)Begoña Mellado (1 shared paper)Ugo De Giorgi (1 shared paper)David F. McDermott (1 shared paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Omara Khan
3 papers receiving 433 citations
Omara Khan's Hit Papers
Peers
Comparison fields: 5 of 30
- Pulmonary and Respiratory Medicine 312
- Cancer Research 83
- Oncology 151
- Surgery 72
- Molecular Biology 100
Countries citing papers authored by Omara Khan
This map shows the geographic impact of Omara Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omara Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omara Khan more than expected).
Fields of papers citing papers by Omara Khan
This network shows the impact of papers produced by Omara Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omara Khan. The network helps show where Omara Khan may publish in the future.
Co-authors
The 17 scholars most cited alongside Omara Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial Hit paper breakdown → | 2022 | 168 |
| 2 | Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2023 | 143 |
| 3 | 2021 | 130 |
About Omara Khan
Omara Khan is a scholar working on Pulmonary and Respiratory Medicine, Insect Science, Renewable Energy, Sustainability and the Environment, Obstetrics and Gynecology and Anesthesiology and Pain Medicine, having authored 3 papers that have together received 441 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (312 citations), Cancer Research (83 citations), Oncology (151 citations), Surgery (72 citations) and Molecular Biology (100 citations). Omara Khan has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robert John Motzer, Daniil Stroyakovskiy, Frede N. Donskov, Sarita Dubey, B. Yа. Alekseev, Begoña Mellado, Ugo De Giorgi, David F. McDermott, Romain Banchereau and Bernard J. Escudier. Their work appears in journals such as The Lancet and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.